Healthcare Value Capital as of March 31, 2017
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 16 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences Call Option (GILD) | 15.7 | $9.2M | 135k | 67.92 | |
| Novelion Therapeutics Com New | 15.3 | $8.9M | 831k | 10.74 | |
| Pfizer (PFE) | 14.6 | $8.6M | 250k | 34.21 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 10.1 | $5.9M | 25k | 235.76 | |
| DepoMed Call Option | 9.7 | $5.6M | 450k | 12.55 | |
| Albany Molecular Research | 7.3 | $4.2M | 302k | 14.03 | |
| Allergan SHS | 6.1 | $3.6M | 15k | 238.93 | |
| Impax Laboratories Call Option | 4.3 | $2.5M | 200k | 12.65 | |
| CryoLife (AORT) | 4.3 | $2.5M | 150k | 16.65 | |
| Teva Pharmaceutical Inds Sponsored Adr (TEVA) | 4.1 | $2.4M | 75k | 32.09 | |
| D Fluidigm Corp Del Call Option (LAB) | 3.2 | $1.9M | 325k | 5.70 | |
| Amarin Corp Spons Adr New (AMRN) | 2.5 | $1.4M | 450k | 3.20 | |
| Proshares Tr Ultsh Nasd Biot Call Option | 1.2 | $695k | 25k | 27.80 | |
| Immunomedics Call Option | 1.1 | $647k | 100k | 6.47 | |
| Zogenix Com New | 0.6 | $346k | 32k | 10.86 | |
| Fibrocell Science Com Par | 0.1 | $32k | 16k | 2.01 |
